chromium has been researched along with Diabetes Mellitus, Adult-Onset in 143 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (2.80) | 18.7374 |
| 1990's | 18 (12.59) | 18.2507 |
| 2000's | 53 (37.06) | 29.6817 |
| 2010's | 55 (38.46) | 24.3611 |
| 2020's | 13 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Covasa, M; Iatcu, CO; Steen, A | 1 |
| Chen, L; Chen, Z; Ge, X; He, X; Huang, Y; Jiang, X; Lin, Z; Liu, B; Liu, T; Xu, W; Zeng, F; Zhao, C; Zhao, L; Zhu, Y | 1 |
| Chen, Y; Jiang, X; Liu, B; Luan, F; Wang, Y; Xu, Y | 1 |
| Li, H; Liao, W; Sun, G; Wang, S; Wang, Y; Xia, H; Xia, J; Xu, D; Xu, H; Yin, S; Yu, J; Zhou, Y | 1 |
| Alkhalidi, F | 1 |
| Akter, QS; Alam, MK; Eva, H | 1 |
| Krejpcio, Z; Król, E; Staniek, H; Szczepankiewicz, D; Szwengiel, A; Tubacka, M; Vincent, JB; White, PE | 1 |
| Ayçiçek, B; Çavdar, Ü; Sennaroğlu, E; Temurer Afşar, Z; Tütüncü, Y | 1 |
| Acevedo-Mackey, D; Acharjee, N; Akhtar, K; Al-Buriahi, MS; Amandi, A; An, Y; Anjum, NA; Asgari, Q; Badiei, B; Baez Vasquez, AY; Bagley, GD; Bahreini, MS; Bajelan, S; Baluja, MQ; Barbieri, MA; Batalha, MA; Bettiol, H; Bhattarai, U; Biset, JC; Bjerg, M; Björnsson, BT; Boag, AM; Borthwick, MS; Boukhris, I; Bragança, MLBM; Breves, JP; Britz-McKibbin, P; Broaddus, RR; Burnell, JE; Camargo, CA; Campo, M; Carlsen, KL; Catchpole, B; Cavalli, L; Chai, C; Chanakya, HN; Chang, AYH; Chantada, A; Chen, W; Chen, X; Chen, Y; Cheng, ZL; Chenoweth, DA; Chhetri, S; Coelho, CCNDS; Coker, ES; Cole, MA; Coniglio, A; Connor, TR; Corbishley, A; D'Arienzo, M; da Silva, AAM; Dai, Y; de Oliveira, BR; Dignac, MF; Dong, A; Dottino, JA; Duo, J; Einarsdottir, IE; Ekanayake, EMDNK; El Fels, L; El Hayany, B; El Shahawy, O; Elliott, RJR; Fabrizi, E; Farkas, K; Fellman, B; Fenoglio, D; Ferrario, M; Flögel, F; Fujiogi, M; Gamage, BD; Ganson, KT; Gao, X; Gärtner, S; Gautam, A; Gautam, S; Gaze, WH; Gosse, JA; Graham, DW; Graham, PA; Guastella, G; Guerrero, S; Gul, M; Guo, B; Guo, X; Gupta, VK; Hafidi, M; Halland, A; Han, W; Hardisty, M; Hasegawa, K; Hess, ST; Heydari, R; Hillary, LS; Holm, R; Huang, L; Jaleh, B; Jayasundara, JASB; Ji, X; Jiang, L; Jones, DL; Kac, G; Kebaili, I; Kelley, JB; Kelum, SHP; Kennedy, LJ; Khan, NA; Khazalpour, S; Khuntia, HK; Kinney, MS; Kommedal, Ø; Koomhin, P; Krawczyk, N; Kæstel, T; Lakmal, MAC; Li, H; Li, K; Li, R; Li, S; Li, W; Li, X; Li, Y; Liang, L; Lin, Y; Lippo, E; Liu, B; Liu, F; Liu, J; Liu, X; Liu, Y; Lodha, D; Loose, DS; López-Meza, P; Lu, F; Lu, KH; Lu, Y; Luo, Y; Ma, B; Malham, SK; Masood, A; Matan, N; McCormick, SD; McDonald, JE; McKenzie, LJ; Melendez, BD; Mikaeili, F; Mir, IR; Mirjalili, MH; Moreno, KP; Moura, IB; Müller, S; Nagata, JM; Nasri, A; Nasrollahzadeh, M; Navarro-Jiménez, E; Nie, E; Nielsen, CU; Nielsen, S; Nøhr, MK; Obeng, B; Odetayo, AA; Ortiz-Barrios, M; Ozgen, C; Pan, X; Parisi, ML; Paskavitz, AL; Patel, AK; Pedersen, M; Pontarollo, N; Potts, CM; Price, C; Pu, Y; Quénéa, K; Rahimi Khonakdari, M; Rather, BA; Raut, P; Regish, AM; Reible, DD; Rezadoost, H; Rizzati, M; Roviello, GN; Roviello, V; Rumpel, C; Sang, J; Sangroula, S; Saraiva, MDCP; Sarker, A; Sayyed, MI; Segoshi, A; Sehar, Z; Shao, X; Shaw, D; Shaw, L; Shekhawat, NS; Shim, JK; Shokouhimehr, M; Short, A; Soliman, PT; Songsamoe, S; Springer-Miller, RH; Stenstad, T; Strobl, E; Sun, R; Syme, H; Thai, L; Tian, G; Tofighi, B; Tonguc, B; Tuyiringire, D; Ulaganathan, N; Ulvestad, E; Varacca, A; Vergalli, S; Verma, DK; Villmones, HC; Wang, D; Wang, H; Wang, J; Wang, L; Wang, M; Wang, S; Wang, Y; Wang, Z; Weedon-Fekjær, H; Weller, SR; West, BE; Wilcox, MH; Wu, W; Wufuer, R; Xia, S; Xiang, H; Xu, H; Yan, L; Yang, RK; Yang, Y; Yates, MS; Ye, Q; Yin, H; Yin, Y; Yuan, Y; Yucesan, M; Yue, W; Zeng, W; Zhang, C; Zhang, D; Zhang, H; Zhang, L; Zhang, Q; Zhang, Y; Zhou, B; Zhou, Y; Zhu, Y; Zhu, Z | 1 |
| Pan, D; Sun, G; Wang, N; Wang, S; Xia, H; Zhang, H; Zhao, F | 1 |
| Asbaghi, O; Ashtary-Larky, D; Eslampour, E; Kelishadi, MR; Moradi, S; Naeini, AA; Naeini, F; Zakeri, N | 1 |
| Asbaghi, O; Ashtary-Larky, D; Clark, CCT; Eslampour, E; Kaviani, M; Mirzadeh, E; Moradi, S; Naeini, AA; Naeini, F; Rezaei Kelishadi, M | 1 |
| Kolahian, S; Larki, NN; Sadri, H | 1 |
| Chen, G; Chen, H; Dong, Y; Huang, H; Zhu, Y | 1 |
| Awe, MA; Ngala, RA; Nsiah, P | 1 |
| Abayaweera, G; Abou-Taleb, HA; AbouElhassan, KM; AbouTaleb, HA; Adair, LS; Adams, E; Addison, O; Addy, I; Akhtar, N; Alten, B; Anesini, J; Añez, R; Angaridis, PA; Aouba, A; Arakawa, K; Aumeeruddy-Elalfi, Z; Bao, LP; Basu, E; Bayraktar, E; Bekkelund, CS; Bell, J; Beraldo, H; Bermúdez, V; Betenbaugh, MJ; Bhattacharya, R; Bienvenu, B; Bolzoni, M; Bootz, F; Borja, JB; Bove, DG; Bowden, ME; Bradsher, C; Brockstedt, D; Brothers, RM; Buschauer, A; Calandriello, L; Caporossi, A; Carba, DB; Carratalà, J; Castella, B; Caviezel, D; Ceccato, R; Charalambidis, G; Charisiadis, A; Chattopadhyay, P; Chen, Q; Chen, W; Chen, Y; Chen, YT; Chen, ZJ; Chen, ZY; Cheng, MA; Cheng, ZB; Cherevko, S; Cheung, IY; Cheung, NV; Chiappini, A; Chiu, YL; Choi, IG; Chough, S; Chung, CY; Cobb, A; Colotto, A; Continentino, MA; Cook, AJMC; Costa, F; Coutsolelos, AG; Cuperus, N; Curtis, BM; Davenport, AJ; de Boysson, H; Dela, F; Deng, XP; Deshayes, S; Dhara, K; Dietrich, D; Dietrich, J; Dilhari, A; Ding, R; Ding, Y; Dirè, S; Dohlmann, TL; Dotsenko, A; Doubrovina, E; Du, K; Du, ZJ; Duvic, M; Eastman, A; Eliakim-Raz, N; Elz, S; Emile, JF; Emmerling, C; Engelhard, MH; Eriksson, JG; Etzold, BJM; Faini, AC; Falsini, B; Farmer, E; Fei, JJ; Ferreira, IP; Föttinger, K; Franconieri, F; Fryda, NJ; Fuentes, I; Galateau-Sallé, F; Ganguly, M; Gani, BA; Gao, X; Gao, XF; Gao, XJ; García-Mendiola, T; Garg, A; Gascon, J; Gayani, B; Gevensleben, H; Gilbert, M; Giudiceandrea, A; Giuliani, N; Gocmen, AY; Goldman, DA; Goltz, D; Gombert, AK; Gomila, A; Goodwin, P; Górnicki, K; Gostin, PF; Graterol, M; Gremillet, C; Grier, S; Grün, AL; Gusakov, A; Halldórsdóttir, HR; Han, L; Han, Z; Hävecker, M; Helge, JW; Heo, K; Hernández, JD; Hindsø, M; Holmen Olofsson, G; Hong, CE; Hong, J; Horenstein, AL; Hosenally, M; Hruz, P; Hsu, HL; Hsu, KC; Hu, SF; Hu, Y; Huang, K; Huang, S; Huang, WH; Humaira, A; Hung, CF; Hung, WS; Huo, XK; Huvinen, E; Idorn, M; Ignatyev, K; Im, WT; Ismaël, IS; Jakobsson, JG; Janaszek-Mańkowska, M; Jeong, GT; Ji, L; Ji, X; Jiang, Y; Jo, IH; Jo, SH; Johnson, AC; Johnson, LE; Kadirvelu, K; Kahnt, A; Kaleta, A; Kamiya, T; Kang, DH; Kang, XH; Kashiwagi, T; Katayama, E; Kawachi, N; Keller, M; Kellermann, L; Khan, T; Khan, ZA; Kharshoum, RM; Khim, JS; Kikuchi, M; Kim, BS; Kim, DS; Kim, DW; Kim, JH; Kim, JJ; Kim, JU; Kim, SK; Kim, WS; Kimura, J; Kiss, C; Knop-Gericke, A; Kobayashi, S; Koivusalo, SB; Kolar, E; Kottegoda, N; Kramer, K; Kristiansen, G; Kruger, AA; Kumar, S; Kumar, V; Kumarage, S; Kursungoz, C; Kushner, BH; Kuwahara, F; Kuzawa, C; Kwon, BO; Landsberg, J; Larsen, S; Lauer, P; Le Luduec, JB; Lee, DW; Lee, H; Lee, HY; Lee, JW; Lee, MJ; Lee, SW; Lefrançois, P; Leibovici, L; Leong, KK; Leong, M; Li, B; Li, D; Li, G; Li, J; Li, YZ; Liang, JH; Liang, X; Liens, A; Ligorio, G; Lin, JD; Lindholm, MG; Liou, MJ; List-Kratochvil, EJW; Litvinov, IV; Liu, F; Liu, S; Liu, Y; Liu, Z; Lohar, S; Lopes, MTP; Lorenzo, E; Lu, X; Lukashuk, L; Lukens, WL; Luo, HR; Luo, L; Luttik, MAH; Ma, Y; MacGowan, A; Mahomoodally, MF; Maissen, S; Malavasi, F; Malhotra, M; Mallik, S; Manna, D; Mans, R; Marangoni, D; Marimpietri, D; Marques, F; Marques, WL; Marsaa, K; Martin Silva, N; Martinez, A; Martínez, MS; Massaia, M; Mayrhofer, KJJ; McDade, T; McNeel, DG; Met, Ö; Micalizio, GC; Modak, S; Morandi, F; Moreau, L; Morla, S; Morrell, AP; Morris, S; Mubarak, Z; Muchlisin, ZA; Munoz, M; Nagao, Y; Nakama, T; Nakamura, H; Nakano, T; Nardi, MV; Nasirian, A; Nelson, MD; Netchiporouk, E; Ni, X; Niess, JH; Nijenhuis, JM; Nikolaou, V; O'Connor, BJ; O'Reilly, RJ; Odobel, F; Ohata, C; Ohyama, B; Olivar, LC; Ordoñez, MG; Ostrovnaya, I; Palmar, J; Panda, S; Pandiyarajan, S; Park, B; Park, H; Park, JH; Park, S; Pasquali, L; Patik, JC; Pearce, CI; Peele, ME; Peng, S; Perera, IC; Petty, JT; Pidko, EA; Pinheiro, CB; Pistoia, V; Pita, M; Planchat, A; Plass, F; Pockes, S; Pradhan, N; Premasudha, P; Pronk, JT; Provost, N; Pujol, M; Qi, P; Qiu, J; Qiu, Z; Quan, J; Quaranta, A; Ra, CH; Rameshan, R; Ranglack, DH; Rausch-Fan, X; Rieger, E; Rivas, JR; Roberts, SS; Rocha, WR; Rodrigues, GLS; Rojas, J; Roy, P; Rozhkova, A; Rufo, S; Rupprechter, G; Saeui, CT; Saha, A; Sakai, M; Salazar, J; Salem, HF; Salgarello, T; Samarakoon, SR; Sandau, C; Sandbeck, DJS; Santos, AF; Santos, VG; Sara, Y; Saslow, SA; Sasseville, D; Sato, S; Sauer, JD; Schlögl, R; Schweiger, MJ; Shashkov, I; Shaw, E; Shen, WQ; Shim, J; Shu, J; Singh, C; Sinha Babu, SP; Sinitsyn, A; Sinitsyna, O; Skadborg, SK; Song, Q; Song, W; Stach-Lempinen, B; Stoddart, M; Stoica, M; Street, SR; Sukwong, P; Sun, CP; Sun, J; Sunwoo, IY; Suresh, S; Szécsényi, Á; Takahashi, T; Takeda, S; Tang, D; Tas, ST; Tebé, C; Teixeira, LR; Teixidor, F; Terrier, B; Teschner, D; Tetzlaff, MT; Theisen, E; Thor Straten, P; Tiitinen, A; Timpel, M; Toccoli, T; Torikai, K; Torres, W; Toscani, D; Trad, S; Tsai, HJ; Tseng, CP; Tucker, WJ; Um, W; Vallejo-Torres, L; van den Broek, M; Van den Heuvel, L; van der Woude, LN; van Maris, AJA; Van Schepdael, A; Vank, C; Verucchi, R; Vigo, JM; Viñas, C; Vogt, TJ; Vuong, C; Wai, H; Wang, B; Wang, D; Wang, H; Wang, JJ; Wang, K; Wang, L; Wang, Q; Wang, YR; Watanabe, S; Watters, AK; Weerasekera, MM; Wei, L; Wheeler, DA; Wiegand, I; Wifling, D; Wijesinghe, GK; Winiczenko, R; Wolker, T; Wu, J; Wu, TC; Wu, YY; Xie, P; Xie, YP; Xu, A; Xu, E; Xu, L; Xu, Z; Yamaguchi, M; Yang, A; Yang, G; Yang, J; Yang, TM; Yang, W; Yang, Y; Yarema, KJ; Yesiltepe, M; Yi, KJ; Yigit, N; Yim, UH; Yin, B; Yu, S; Zengin, G; Zhang, B; Zhang, C; Zhang, GR; Zhang, H; Zhang, J; Zhang, L; Zhang, TY; Zhang, X; Zhang, Y; Zhang, YX; Zhao, H; Zhao, JC; Zhao, Z; Zheng, R; Zhou, W; Zorn Morales, N | 1 |
| Guo, W; Jia, Y; Xu, J; Zhou, Q | 1 |
| Amirani, E; Asemi, Z; Bahmani, F; Farrokhian, A; Mahmoodian, M; Shafabakhsh, R | 1 |
| Chen, YL; Hsia, TL; Hsu, CH; Lin, JD; Mao, FC; Pei, D | 1 |
| Abdollahi, M; Farshchi, A; Nikfar, S; Seyedifar, M | 1 |
| Fabry, J; Mainz, J; Moesgaard, S; Müller, L; Racek, J; Rácová, K; Sindberg, CD | 1 |
| Guimarães, MM; Martins Silva Carvalho, AC; Silva, MS | 1 |
| Adem, A; Agil, A; Blanca-Herrera, RM; Kaki, A; Navarro-Alarcon, M; Ruiz-Ojeda, FJ | 1 |
| Henry, J; Kaur, B | 1 |
| Li, M; Li, WH; Ping, F; Wang, ZX; Xiao, XH; Yu, M; Zhang, HB; Zhang, Q; Zheng, J | 1 |
| Li, M; Li, W; Ping, F; Wang, Z; Xiang, H; Xiao, X; Yu, M; Zhang, H; Zhang, Q; Zheng, J | 1 |
| Vincent, JB | 4 |
| Kertesz, J; Mackler, L; Meyer, A; Moona, MM; Smits, R | 1 |
| Bawazeer, N; Joy, SS; Siddiqui, K | 1 |
| Acosta, AM; Belmar, C; Berkowitz, L; Borzone, GR; Busso, D; Escalona, M; Goldenberg, D; Mertens, N; Olmos, PR; Poblete, JA; Samith, B; Santos, JL; Vera, C | 1 |
| Boettiger, CA; Brownley, KA; Cefalu, WT; Young, L | 1 |
| Feng, W; Feng, Y; Jin, D; Li, F; Mao, G; Wang, W; Wu, H; Wu, X; Yang, L; Zhao, T; Zheng, D | 1 |
| Phung, OJ; Yin, RV | 1 |
| Krebs, JD; Parry-Strong, A; Walsh, E; Weatherall, M; Whitfield, P | 1 |
| Amani, M; Kolahian, S; Mazadeh, A; Mirani, M; Sadri, H; Shahbazfar, AA | 1 |
| Allatif, O; Bastard, JP; Bieuvelet, S; Brochot, A; Clément, K; Cotillard, A; Fellahi, S; Guilbot, A; Langlois, C; Liu, Y; Rizkalla, SW; Stévant, M; Vatier, C | 1 |
| Anderson, ME; Blanco, P; Castro, MC; Dedman, J; Kaetzel, M; Mattiazzi, A; Palomeque, J; Rueda, OV; Sommese, L; Valverde, CA | 1 |
| Brownstein, JS; Goldfine, AB; Grizales, AM; McIver, DJ | 1 |
| Camina-Martín, MA; Collado-Yurrita, L; Garicano-Vilar, E; Mateo-Silleras, Bd; Redondo Del Río, Mde P; Ruiz-León, AM; San Mauro-Martin, I | 1 |
| Carvalho, AC; Guimarães, MM; Silva, MS | 1 |
| Bailey, RL; Costello, RB; Dwyer, JT | 1 |
| Al-Mrabeh, A; Aribasala, B; Batterham, RL; Hollingsworth, KG; Pucci, A; Small, PK; Steven, S; Taylor, R; Woodcock, SA | 1 |
| Gabriel, C; Kafantari, M; Salifoglou, A; Tsave, O; Yavropoulou, MP; Yovos, JG | 1 |
| Abeliatis, A; Karathanos, VT; Konstantopoulos, P; Nikolakea, I; Perrea, D; Stamataki, NS; Stoupaki, M; Tentolouris, N; Yanni, AE | 1 |
| Chen, H; Chen, Z; Gao, X; Pan, Y; Wang, C | 1 |
| Gong, M; Kong, D; Li, Y; Liu, C; Yi, X; Zhang, J; Zheng, X | 1 |
| Bao, W; Chen, S; Cheng, J; Cheng, Q; Jin, X; Li, S; Liu, L; Luo, C; Shan, Z; Sun, T; Yang, W; Yao, P; Yin, J; Yu, K; Zhang, Y | 1 |
| Chen, CJ; Chen, WY; Liu, CH; Mao, FC | 1 |
| Bilo, HJ; Groenier, KH; Houweling, ST; Kleefstra, N | 2 |
| Apostoli, P; Catalani, S; Liberini, P; Padovani, A; Pazzaglia, U; Rizzetti, MC; Zarattini, G | 1 |
| Moher, M; Nahas, R | 1 |
| Bull, R; Croad, JL; Jain, SK; Rains, JL; Velusamy, T | 1 |
| Cefalu, WT; Wang, ZQ | 1 |
| Khan, MR; Mujeeb, M; Parveen, K; Siddiqui, WA | 1 |
| Chung, HS; Jun, HJ; Kim, MK; Kim, TK; Ko, JH; Ko, KS; Kwon, MJ; Lee, SH; Park, JH; Rhee, BD; Yoon, CS | 1 |
| Cefalu, WT | 1 |
| Agca, CA; Guvenc, M; Hayirli, A; Krejpcio, Z; Orhan, C; Sahin, K; Sahin, N; Staniek, H; Tuzcu, M | 1 |
| Bogdański, P; Byks, H; Krejpcio, Z; Król, E; Pupek-Musialik, D | 1 |
| Golubnitschaja, O; Peeva, V; Schild, HH; Shenoy, A; Yeghiazaryan, K | 1 |
| Gambhir, PS; Phadke, MA | 1 |
| Agarwal, V; Agrawal, RP; Choudhary, M; Goyal, S; Jain, S; Sharma, S | 1 |
| Cassady, CJ; Chen, Y; Gao, J; Sinha, SH; Vincent, JB; Watson, HM | 1 |
| Padmavathi, IJ; Raghunath, M; Rao, KR | 1 |
| Esmaillzadeh, A; Khosravi-Boroujeni, H; Ravanshad, S; Rostami, A | 1 |
| Chen, H; Tan, C | 1 |
| Basaki, M; Nazifi, S; Saeb, M; Shamsaei, HA | 1 |
| Clark, S; Hua, Y; Ren, J; Sreejayan, N | 1 |
| Atalay, M; Gencoglu, H; Hayirli, A; Komorowski, JR; Orhan, C; Sahin, K; Sahin, N; Tuzcu, M; Ulas, M | 1 |
| Liu, XL; Lü, XF; Shao, C; Wang, P; Xiao, XH; Xu, ZR; Yang, WY; Yang, ZJ | 1 |
| Love, ST; Vincent, JB | 1 |
| Afridi, HI; Brabazon, D; Kazi, TG; Naher, S; Talpur, FN | 1 |
| Lamson, DW; Plaza, SM | 1 |
| Chowka, P; Head, K | 1 |
| Anderson, RJ; Claassen, JP; Wells, IC | 1 |
| Cook, CB; Redman, AR; Ryan, GJ; Wanko, NS | 1 |
| Ekin, S; Gunduz, H; Meral, I; Mert, N | 1 |
| Bhattacharya, B; Chowdhury, S; Pandit, K; Roychowdury, P | 1 |
| Brown, M | 1 |
| Bakker, SJ; Bilo, HJ; Houweling, ST; Kleefstra, N | 1 |
| Yki-Järvinen, H | 1 |
| Cheng, HH; Hou, WC; Huang, CL; Lai, MH | 1 |
| Tilbrook, L | 1 |
| Havel, PJ | 1 |
| Kordella, T | 1 |
| Friedensohn, A; Gabay, G; Habot, B; Leibovitz, A; Rabinovitz, H; Rocas, C | 1 |
| Gmoshinskiĭ, IV; Mazo, VK; Meshcheriakova, VA; Nechaeva, SV; Plotnikova, OA; Sharafetdinov, KhKh | 1 |
| Anderson, RA; Briski, A; Kocijancic, A; Radovancevic, B; Vrtovec, B; Vrtovec, M | 1 |
| Fukuchi, Y; Fukuya, Y; Ishihara, K; Mita, Y; Yasumoto, K | 1 |
| Bakker, SJ; Bilo, HJ; Gans, RO; Groenier, KH; Houweling, ST; Jansman, FG; Kleefstra, N; Meyboom-de Jong, B | 1 |
| Collins, M; McFarlane, JR | 1 |
| Hunter, D; Mudrová, V; Racek, J; Rajdl, D; Senft, V; Trefil, L | 1 |
| Arabadjiiska, DT; Terzieva, DD; Vladeva, SV | 1 |
| Bagchi, D; Khanna, S; Rink, C; Rink, T; Roy, S; Sen, CK | 1 |
| Mark, DA | 1 |
| Dolinsek, F; Stupar, J; Vrtovec, M | 1 |
| Bakker, SJ; Bilo, HJ; Gans, RO; Houweling, ST; Kleefstra, N; Meyboom-de Jong, B; Verhoeven, S | 1 |
| Daly, A; Finch, M; Geohas, J; Juturu, V; Komorowski, JR | 1 |
| Albarracin, C; Finch, MR; Fuqua, B; Geohas, J; Juturu, V; Komorowski, JR | 1 |
| Aguilar, MV; Arrieta, FJ; González, MJ; Martínez-Para, MC; Mateos, CJ; Meseguer, I; Saavedra, P | 1 |
| Vinson, JA | 1 |
| Croad, JL; Jain, SK; Rains, JL | 1 |
| Hummel, M; Schnell, O; Standl, E | 1 |
| Anderson, RA; Cefalu, WT; Martin, J; Pinsonat, P; Qin, J; Sereda, O; Wang, ZQ; Zhang, XH | 1 |
| Afridi, HI; Arain, MB; Jalbani, N; Jamali, MK; Kandhro, GA; Kazi, N; Kazi, TG | 1 |
| Anderson, RA | 4 |
| Dong, F; Kandadi, MR; Ren, J; Sreejayan, N; Yang, X | 1 |
| Hersio, K; Koivistoinen, P; Kumpulainen, J; Lehto, J; Pyörälä, K; Sarlund, H; Uusitupa, M; Voutilainen, E | 1 |
| Elias, AN; Grossman, MK; Valenta, LJ | 1 |
| Mahdi, GS | 2 |
| Ravina, A; Slezack, L | 1 |
| Mertz, W | 1 |
| Dimitrijević, V; Djordjević, PB; Maksimović, R; Vrvić, M; Vucetić, J | 1 |
| Porter-Field, LM | 1 |
| Rodríguez-Iturbe, B; Romero, RA; Salgado, O; Tahán, JE | 1 |
| Gropper, SS; Thomas, VL | 1 |
| Davies, S; Howard, M; Hunnisett, A; McLaren Howard, J | 1 |
| Linday, LA | 1 |
| Anderson, RA; Bryden, NA; Cheng, N; Chi, J; Feng, J; Polansky, MM | 1 |
| Mestek, O; Nĕmecek, K; Tesar, V; Tesarová, P; Zák, A; Zeman, M; Zima, T | 1 |
| Hellerstein, MK | 1 |
| Burgin, C; Gray, TA; Hardisty, CA; Heller, S; MacNeil, S; Morris, BW | 1 |
| Anderson, RA; Preuss, HG | 1 |
| Crews, HM; Fairweather-Tait, SJ; Greenwood, RH; Lewis, J; Sampson, MJ; Self, KA; Trow, LG | 1 |
| Kuritzky, L; Quillen, DM; Samraj, GP | 1 |
| McCarty, MF | 1 |
| Heller, S; Kouta, S; MacNeil, S; Morris, BW; Robinson, R | 1 |
| Ekmekcioglu, C; Marktl, W; Pomazal, K; Prohaska, C; Schernthaner, G; Steffan, I | 1 |
| Anderson, RA; Kerkeni, A; Mahjoub, S; Matheau, JM; Roussel, AM; Zouari, N | 1 |
| Bahijri, SM; Mufti, AM | 1 |
| Rükgauer, M; Zeyfang, A | 1 |
| Anderson, RA; Bryden, NA; Bureau, I; Favier, M; Polansky, MM; Roussel, AM | 1 |
| Althuis, MD; Jordan, NE; Ludington, EA; Wittes, JT | 1 |
| Abraham, AS; Brooks, BA; Eylath, U | 1 |
| el-Yazigi, A; Hannan, N; Raines, DA | 1 |
| Diemann, E; Müller, A; Sassenberg, P | 1 |
35 review(s) available for chromium and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Gut Microbiota and Complications of Type-2 Diabetes.
Topics: Amino Acids; Animals; Chromium; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Dysbiosis; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Insulin Resistance; Nicotinic Acids; Patient Acuity; Prebiotics; Probiotics; Synbiotics | 2021 |
Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials.
Topics: Cholesterol; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Micronutrients; Minerals; Network Meta-Analysis; Niacin; Primary Health Care; Randomized Controlled Trials as Topic; Vanadium; Vitamin E; Vitamin K; Vitamins | 2023 |
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollutants, Occupational; Amino Acid Transport Systems; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Arthrobacter; Bacteria; Bacteriological Techniques; Benzaldehydes; Biodegradation, Environmental; Biofilms; Biological Transport; Biomarkers; Biomass; Bioreactors; Body Composition; Body Mass Index; Brassica; Brazil; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Caco-2 Cells; Cadmium; Calcium; Calcium Carbonate; Calcium Channels; Catalysis; Cell Degranulation; Cell Line; Cell Membrane; Chitosan; Chromatography, High Pressure Liquid; Chromium; Cobalt; Cohort Studies; Colony Count, Microbial; Composting; Copper; COVID-19; Cross-Sectional Studies; Cytoplasm; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diarrhea; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Synergism; Electroplating; Endometrial Neoplasms; Endometrium; Environmental Monitoring; Environmental Restoration and Remediation; Estradiol; Estrogens; Feces; Female; Food Microbiology; Food Preservation; Fruit and Vegetable Juices; Gasotransmitters; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Glutathione; Gold; Graphite; Growth Hormone; Harm Reduction; Hot Temperature; Humans; Hydrocortisone; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydrogen-Ion Concentration; Ileum; Imidazoles; Injections, Intraperitoneal; Insecticides; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Intestinal Absorption; Light; Lignin; Liver; Magnetics; Male; Manganese; Mast Cells; Melanoma; Membrane Potentials; Metals; Methadone; Microbial Viability; Microplastics; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Middle Aged; Mitochondrial Swelling; Molecular Dynamics Simulation; Monophenol Monooxygenase; Morocco; Naloxone; Naltrexone; Nanocomposites; Nanomedicine; Nanoparticles; Narcotic Antagonists; Neonicotinoids; Nitric Oxide; Nitro Compounds; Nitrogen; Nitrogen Compounds; Obesity; Obesity, Abdominal; Occupational Exposure; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oryza; Overweight; Oxidative Stress; Oxides; Oxygen; Perception; Photoelectron Spectroscopy; Plants; Plastics; Point Mutation; Polychlorinated Biphenyls; Polycyclic Aromatic Hydrocarbons; Potassium; Premenopause; Prodrugs; Prospective Studies; Protons; Pyrolysis; Qualitative Research; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resins, Synthetic; Rhodamines; Risk Factors; ROC Curve; Salmo salar; SARS-CoV-2; Seawater; Severity of Illness Index; Sewage; Social Media; Soil; Soil Microbiology; Soil Pollutants; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Staining and Labeling; Stainless Steel; Steel; Stress, Physiological; Substance Abuse Treatment Centers; Symporters; T-Lymphocytes; Toluene; Triclosan; Ultraviolet Rays; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Purification; Welding; X-Ray Diffraction; Young Adult | 2020 |
Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis.
Topics: Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Glycated Hemoglobin; Humans; Lipids; Randomized Controlled Trials as Topic | 2022 |
Effects of chromium supplementation on lipid profile in patients with type 2 diabetes: A systematic review and dose-response meta-analysis of randomized controlled trials.
Topics: Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Dose-Response Relationship, Drug; Humans; Lipids; Randomized Controlled Trials as Topic | 2021 |
Effects of chromium supplementation on blood pressure, body mass index, liver function enzymes and malondialdehyde in patients with type 2 diabetes: A systematic review and dose-response meta-analysis of randomized controlled trials.
Topics: Blood Pressure; Body Mass Index; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Liver; Malondialdehyde; Randomized Controlled Trials as Topic | 2021 |
Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials.
Topics: Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids | 2013 |
Micronutrient status in type 2 diabetes: a review.
Topics: Biomarkers; Blood Glucose; Chromium; Copper; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Synergism; Evidence-Based Medicine; Humans; Iron; Magnesium; Manganese; Micronutrients; Nutritional Status; Selenium; Vitamins; Zinc | 2014 |
Is chromium pharmacologically relevant?
Topics: Animals; Chromium; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Lipid Metabolism; Rats | 2014 |
Clinical inquiry: do complementary agents lower HbA1c when used with standard type 2 diabetes therapy?
Topics: Chromium; Cinnamomum zeylanicum; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Ipomoea batatas; Phytotherapy; Randomized Controlled Trials as Topic; Safflower Oil; Silybum marianum; Trace Elements; Trigonella | 2014 |
Variation in macro and trace elements in progression of type 2 diabetes.
Topics: Calcium; Chromium; Cobalt; Copper; Diabetes Mellitus, Type 2; Disease Progression; Humans; Iodine; Iron; Magnesium; Manganese; Micronutrients; Minerals; Potassium; Selenium; Sodium; Trace Elements; Vanadium; Zinc | 2014 |
Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Chlorides; Chromium; Chromium Compounds; Diabetes Mellitus, Type 2; Dietary Supplements; Fasting; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Picolinic Acids; Saccharomyces cerevisiae; Trace Elements; Treatment Outcome | 2015 |
[Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials].
Topics: Chromium; Diabetes Mellitus, Type 2; Humans; Randomized Controlled Trials as Topic; Trace Elements | 2016 |
Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness.
Topics: Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Fasting; Glycated Hemoglobin; Humans; Randomized Controlled Trials as Topic | 2016 |
Complementary and alternative medicine for the treatment of type 2 diabetes.
Topics: Animals; Blood Glucose; Camellia sinensis; Chromium; Cinnamomum zeylanicum; Diabetes Mellitus, Type 2; Dietary Fiber; Evidence-Based Medicine; Glycated Hemoglobin; Gymnema; Humans; Momordica charantia; Phytotherapy; Plant Preparations; Tea; Trace Elements; Treatment Outcome; Trigonella; Vanadium | 2009 |
Current concepts about chromium supplementation in type 2 diabetes and insulin resistance.
Topics: Chromium; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Insulin Resistance | 2010 |
Molecular mechanisms of chromium in alleviating insulin resistance.
Topics: Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Early Medical Intervention; Exercise; Humans; Insulin Resistance; Life Style; Obesity; Phosphorylation; Randomized Controlled Trials as Topic; Receptor, Insulin | 2012 |
The need for combined inorganic, biochemical, and nutritional studies of chromium(III).
Topics: Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Humans | 2012 |
The safety and efficacy of high-dose chromium.
Topics: Adult; Blood Glucose; Chromium; Chromium Compounds; Diabetes Mellitus, Type 2; Dietary Supplements; Dose-Response Relationship, Drug; Female; Glucose; Humans; Male; Middle Aged; Nutritional Requirements; Randomized Controlled Trials as Topic | 2002 |
Chromium as adjunctive treatment for type 2 diabetes.
Topics: Animals; Chromium; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans | 2003 |
Role of chromium in human metabolism, with special reference to type 2 diabetes.
Topics: Animals; Blood Glucose; Chromium; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypercholesterolemia; Insulin; Osteoporosis | 2003 |
[Chromium and insulin resistance].
Topics: Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Glycated Hemoglobin; Humans; Hypoglycemia; Insulin Resistance | 2004 |
Nonglycemic effects of insulin.
Topics: Amino Acids; Cardiovascular Diseases; Chromium; Diabetes Mellitus, Type 2; Endothelium; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Nicotinic Acids; Platelet Aggregation; Vasodilation | 2003 |
Recent advances in the nutritional biochemistry of trivalent chromium.
Topics: Animals; Blood Glucose; Carrier Proteins; Chromium; Diabetes Mellitus, Type 2; Diet; Dietary Supplements; Humans; Insulin; Nutritional Physiological Phenomena; Nutritional Requirements; Picolinic Acids; Receptor, Insulin | 2004 |
A scientific review: the role of chromium in insulin resistance.
Topics: Animals; Cardiovascular Diseases; Chromium; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Metabolic Syndrome; Risk Factors | 2004 |
Recent developments in the biochemistry of chromium(III).
Topics: Animals; Biochemical Phenomena; Biochemistry; Chromium; Controlled Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans | 2004 |
Chromium in metabolic and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Chromium; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Insulin; Metabolic Diseases; Metabolic Syndrome; Models, Biological; Nutritional Requirements; Risk Factors | 2007 |
Chromium in human nutrition: a review.
Topics: Animals; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Lipid Metabolism; Nutritional Physiological Phenomena; Parenteral Nutrition, Total | 1993 |
Is chromium supplementation effective in managing type II diabetes?
Topics: Animals; Blood Glucose; China; Chromium; Controlled Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Supplements; Humans | 1998 |
Chromium update: examining recent literature 1997-1998.
Topics: Aging; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Nutritional Requirements; Obesity | 1998 |
Improving management of type 2 diabetes mellitus: 6. Chromium.
Topics: Blood Glucose; Cholesterol; Chromium; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Insulin; Nutritional Requirements | 2000 |
Chromium in the prevention and control of diabetes.
Topics: Animals; Chromium; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glucose Intolerance; Humans; Insulin Resistance; Parenteral Nutrition, Total; Pregnancy | 2000 |
Quest for the molecular mechanism of chromium action and its relationship to diabetes.
Topics: Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Glucose Intolerance; Humans; Oligopeptides | 2000 |
Glucose and insulin responses to dietary chromium supplements: a meta-analysis.
Topics: Blood Glucose; Chromium; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Fasting; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; MEDLINE; Placebos; Randomized Controlled Trials as Topic | 2002 |
Chromium metabolism and its role in disease processes in man.
Topics: Adult; Aged; Blood Glucose; Child; Chromium; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Feeding Behavior; Female; Glucose Tolerance Test; Humans; Hypoglycemia; Pregnancy; Stress, Physiological | 1986 |
31 trial(s) available for chromium and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
A comparative study to assess the use of chromium in type 2 diabetes mellitus.
Topics: Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Middle Aged; Single-Blind Method | 2023 |
Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosphate; Adipose Tissue; Administration, Intravaginal; Adolescent; Adsorption; Adult; Adverse Childhood Experiences; Age Distribution; Age Factors; Aged; Aged, 80 and over; Air Pollution, Indoor; Aldehyde Oxidase; Alginates; Alloys; alpha-Globins; Aluminum Hydroxide; Alveolar Bone Loss; Anaerobiosis; Anesthesia, General; Anesthetics; Animals; Anovulation; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bacillus cereus; Bacterial Typing Techniques; Bacteroidetes; Base Composition; Biocompatible Materials; Biofilms; Biological Availability; Biological Transport; Biosensing Techniques; Bipolar Disorder; Blood Glucose; Body Mass Index; Bone Regeneration; Boranes; Brachial Artery; Butyric Acid; Candida albicans; Carbon; Carcinoembryonic Antigen; Cell Differentiation; Cell Line, Tumor; Cell Respiration; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Charcoal; Child; Child Health; China; Chloride Channels; Chlorides; CHO Cells; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromium; Chronic Disease; Chronic Periodontitis; Circular Dichroism; Cities; Cohort Studies; Comamonadaceae; Comorbidity; Coronary Artery Disease; Corrosion; Cricetinae; Cricetulus; Cross Infection; Cross-Sectional Studies; Crowding; Culture Media; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diarylheptanoids; Diclofenac; Disability Evaluation; Diterpene Alkaloids; DNA; DNA Mutational Analysis; DNA, Bacterial; Drug Liberation; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Electrodes; Electrolytes; Endothelium, Vascular; Enterococcus faecalis; Epithelial Cell Adhesion Molecule; Epithelial Cells; Erbium; Erythropoietin; Ethanol; Ethylenediamines; Fast Foods; Fatty Acids; Female; Fermentation; Ferric Compounds; Fibroblasts; Flavobacteriaceae; Fluorides; Fluorodeoxyglucose F18; Food Microbiology; Formaldehyde; Furaldehyde; Gamma Cameras; Gene Expression; Geologic Sediments; Glucose Tolerance Test; Glycated Hemoglobin; Glycolipids; Glycosylation; Gracilaria; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guanine; Health Surveys; HeLa Cells; Hemoglobins, Abnormal; Hexosamines; High Fructose Corn Syrup; High-Intensity Interval Training; Hip Fractures; Hippocampus; HLA-B27 Antigen; Hospitalization; Housing; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Hypercapnia; Hypertension; Hypocreales; Hypromellose Derivatives; Image Processing, Computer-Assisted; Incidence; Indole Alkaloids; Indonesia; Inflammation Mediators; Infrared Rays; Insulin Resistance; Intercalating Agents; Ion Transport; Ionophores; Japan; Kinetics; Kluyveromyces; Letrozole; Linear Models; Lipopolysaccharides; Liposomes; Liver; Lung Diseases; Magnesium Hydroxide; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Mitochondria, Muscle; Molecular Docking Simulation; Molecular Structure; Muscle, Skeletal; Mutant Proteins; Mutation; Mutation, Missense; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Obesity; Occupational Exposure; Oceans and Seas; Odds Ratio; Organometallic Compounds; Osteogenesis; Ovulation Induction; Oxidation-Reduction; Particle Size; Periodontal Ligament; Permeability; Phaseolus; Phenotype; Philippines; Phosphatidylethanolamines; Phospholipids; Photochemical Processes; Phylogeny; Pichia; Pigmentation; Plant Extracts; Polycystic Ovary Syndrome; Polysaccharides; Postprandial Period; Pregnancy; Pregnancy Rate; Prevalence; Product Surveillance, Postmarketing; Progesterone; Progestins; Protein Engineering; Pseudomonas aeruginosa; Psoriasis; Public Facilities; Rats; Rats, Wistar; Receptors, Thyrotropin; Recombinant Proteins; Reproducibility of Results; Republic of Korea; Retrospective Studies; Rhodobacteraceae; Risk; Risk Assessment; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Saccharomyces cerevisiae; Salinity; Saliva; Seawater; Seaweed; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Silver Compounds; Smokers; Social Class; Socioeconomic Factors; Soil Microbiology; Solubility; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Spondylitis, Ankylosing; Staphylococcus aureus; Static Electricity; Steroids; Strontium; Sucrose; Surface Properties; Survival Rate; Sweden; Swine; Synapses; Synchrotrons; Tandem Mass Spectrometry; Tannins; Tea; Temperature; Terpenes; Thalidomide; Thermodynamics; Thiadiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tissue Distribution; Titanium; Toilet Facilities; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ubiquinone; Urinary Tract Infections; Vaginal Creams, Foams, and Jellies; Venezuela; Vitamin K 2; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Microbiology; Water Pollutants, Chemical; Whole Body Imaging; X-Ray Diffraction; Young Adult; Ytterbium; Yttrium; Yttrium Radioisotopes; Zinc Compounds | 2018 |
The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease.
Topics: Blood Glucose; C-Reactive Protein; Chromium; Coronary Disease; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Humans | 2020 |
The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol; Chromium; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Secretion; Interleukin-6; Male; Middle Aged; Prospective Studies; Triglycerides; Tumor Necrosis Factor-alpha; Uric Acid | 2014 |
Effect of chromium-enriched yeast on fasting plasma glucose, glycated haemoglobin and serum lipid levels in patients with type 2 diabetes mellitus treated with insulin.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Administration Schedule; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Time Factors; Treatment Outcome; Yeast, Dried | 2013 |
Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Male; Middle Aged; Nicotinic Acids; Organometallic Compounds | 2013 |
The effect of a cinnamon-, chromium- and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial.
Topics: Aged; Blood Glucose; Body Weight; Cholesterol; Chromium; Cinnamomum zeylanicum; Cross-Over Studies; Diabetes Mellitus, Type 2; Energy Intake; Female; Food, Fortified; Glycated Hemoglobin; Honey; Humans; Insulin; Magnesium; Male; Middle Aged; Treatment Outcome; Weight Loss | 2016 |
A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial.
Topics: Adult; Aged; Blood Glucose; Body Composition; Carnosine; Chromium; Cinnamomum zeylanicum; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Fasting; Female; Humans; Male; Middle Aged; Muscles; Obesity; Overweight; Placebos; Plant Extracts; Prediabetic State | 2015 |
Effect of chromium supplementation on the glucose homeostasis and anthropometry of type 2 diabetic patients: Double blind, randomized clinical trial: Chromium, glucose homeostasis and anthropometry.
Topics: Adult; Anthropometry; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucose; Homeostasis; Humans; Male; Middle Aged | 2016 |
Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes.
Topics: Adipose Tissue; Adult; Aged; Amino Acids; Arginine; Blood Glucose; Body Composition; Caloric Restriction; Chromium; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon-Like Peptide 1; Glucose; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipase; Liver; Male; Membrane Proteins; Middle Aged; Nicotinic Acids; Pancreas; Triglycerides | 2016 |
Controlling type-2 diabetes by inclusion of Cr-enriched yeast bread in the daily dietary pattern: a randomized clinical trial.
Topics: Aged; Blood Glucose; Bread; Chromium; Diabetes Mellitus, Type 2; Diet; Female; Food, Fortified; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Middle Aged; Placebos; Saccharomyces cerevisiae; Single-Blind Method; Triticum | 2018 |
Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients.
Topics: Adult; Blood Glucose; Chromium; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Hair; Humans; Hypoglycemic Agents; Lipid Metabolism; Lipids; Male; Middle Aged; Minerals; Saccharomyces cerevisiae | 2011 |
Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes.
Topics: Adult; Aged; Blood Glucose; Case-Control Studies; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Glycated Hemoglobin; Humans; Lipids; Middle Aged | 2011 |
[Efficacy of tianmaixiaoke tablets in the treatment of newly diagnosed type 2 diabetes mellitus in China].
Topics: Adult; Aged; Aged, 80 and over; China; Chromium; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Picolinic Acids; Pyrazines; Sitagliptin Phosphate; Triazoles | 2012 |
Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects.
Topics: Antioxidants; Catalase; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Oxidative Stress; Placebos; Thiobarbituric Acid Reactive Substances | 2004 |
Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus.
Topics: Chromium; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Electrocardiography; Heart Conduction System; Humans; Picolinic Acids | 2005 |
Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Blood Pressure; Body Mass Index; Chromium; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Middle Aged; Obesity; Picolinic Acids | 2006 |
An exploratory study into the effectiveness of a combination of traditional Chinese herbs in the management of type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Phytotherapy; Plant Preparations | 2006 |
Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus.
Topics: Aged; Biomarkers; Blood Glucose; Body Mass Index; Chromium; Diabetes Mellitus, Type 2; Female; Glutathione Peroxidase; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Middle Aged; Oxidative Stress; Superoxide Dismutase; Yeast, Dried | 2006 |
Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Chromium; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Lipids; Male; Middle Aged; Netherlands; Placebos; Reproducibility of Results; Treatment Outcome | 2007 |
Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.
Topics: Adult; Biotin; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Chromium; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Picolinic Acids; Triglycerides | 2007 |
Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial.
Topics: Adolescent; Adult; Aged; Biotin; Blood Glucose; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Chromium; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypercholesterolemia; Male; Middle Aged; Risk Factors | 2007 |
Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.
Topics: Adult; Aged; Blood Glucose; Body Composition; Body Weight; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin Resistance; Linear Models; Male; Middle Aged | 2007 |
[The effect of chromium supplementation on glucose tolerance, insulin response and serum lipids in maturity-onset diabetes].
Topics: Adult; Aged; Chromium; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Insulin; Lipids; Male; Middle Aged | 1984 |
Application of organic bound chrome in disturbed glycoregulation therapy.
Topics: Amino Acids; Chromium; Cross-Over Studies; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin Resistance; Nicotinic Acids; Obesity | 1995 |
Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Chromium; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Insulin; Lipids; Male; Middle Aged; Niacin; Risk Factors; Triglycerides | 1996 |
Trivalent chromium and the diabetes prevention program.
Topics: Chromans; Chromium; Clinical Protocols; Complementary Therapies; Diabetes Mellitus, Type 2; Diet; Exercise; Glucose Intolerance; Humans; Hypoglycemic Agents; Metformin; Safety; Thiazoles; Thiazolidinediones; Troglitazone | 1997 |
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Picolinic Acids; Placebos; Postprandial Period | 1997 |
Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus.
Topics: Adult; Antioxidants; Blood Glucose; Chromium; Copper; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Glutathione Peroxidase; Glycated Hemoglobin; Humans; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Selenium; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tunisia; Zinc | 2001 |
Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status.
Topics: Adult; Aged; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Male; Middle Aged | 2002 |
The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Blood Glucose; Cholesterol, HDL; Chromium; Diabetes Mellitus, Type 2; Female; Humans; Lipids; Male; Middle Aged | 1992 |
77 other study(ies) available for chromium and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
6,8-(1,3-Diaminoguanidine) luteolin and its Cr complex show hypoglycemic activities and alter intestinal microbiota composition in type 2 diabetes mice.
Topics: Animals; Chromium; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Glycogen Synthase Kinase 3 beta; Guanidines; Hypoglycemic Agents; Luteolin; Mice; Organometallic Compounds; Phosphatidylinositol 3-Kinases | 2022 |
Associations between whole blood trace elements concentrations and HbA1c levels in patients with type 2 diabetes.
Topics: Blood Glucose; Chromium; Cobalt; Copper; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Iron; Lipids; Lithium; Manganese; Molybdenum; Selenium; Strontium; Trace Elements; Vanadium; Zinc | 2022 |
Relationship between Glycemic Status and Serum Chromium Level with Type 2 Diabetes Mellitus.
Topics: Adult; Bangladesh; Blood Glucose; Chromium; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Spectrophotometry, Atomic | 2020 |
Effects of Bitter Melon and a Chromium Propionate Complex on Symptoms of Insulin Resistance and Type 2 Diabetes in Rat Models.
Topics: Animals; Chromium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin Resistance; Male; Momordica charantia; Propionates; Rats; Rats, Wistar | 2021 |
Relationships between microvascular complications of diabetes mellitus and levels of macro and trace elements.
Topics: Adult; Aged; Chromium; Copper; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Middle Aged; Trace Elements; Zinc | 2023 |
Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats with Type 2 Diabetes.
Topics: Animals; Blood Glucose; Chromium; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dietary Supplements; Glyburide; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Leucine; Lipids; Male; Random Allocation; Rats, Wistar; Streptozocin; Zinc | 2017 |
Chromium supplementation for adjuvant treatment of type 2 diabetes mellitus: Results from a pooled analysis.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Humans; Insulin Resistance; Lipids; Male; Middle Aged | 2018 |
The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study.
Topics: Adult; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chromium; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Insulin Resistance; Lipids; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Obesity; Risk Factors | 2018 |
Comparison of Chromium and Iron Distribution in Serum and Urine among Healthy People and Prediabetes and Diabetes Patients.
Topics: Adult; Aged; Blood Glucose; China; Chromium; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Humans; Iron; Male; Middle Aged; Prediabetic State; Zinc | 2019 |
Melatonin administration in diabetes: regulation of plasma Cr, V, and Mg in young male Zucker diabetic fatty rats.
Topics: Animals; Chromium; Diabetes Mellitus, Type 2; Diet, High-Fat; Humans; Insulin; Magnesium; Male; Melatonin; Rats; Rats, Zucker; Vanadium | 2014 |
Chromium-containing traditional Chinese medicine, Tianmai Xiaoke Tablet improves blood glucose through activating insulin-signaling pathway and inhibiting PTP1B and PCK2 in diabetic rats.
Topics: Animals; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Insulin; Insulin Resistance; Male; Medicine, Chinese Traditional; Phosphoenolpyruvate Carboxykinase (ATP); Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction; Tablets | 2014 |
miR-375 and miR-30d in the effect of chromium-containing Chinese medicine moderating glucose metabolism.
Topics: Animals; Body Weight; Chromium; Chromium Compounds; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; MicroRNAs; Random Allocation; Rats; Rats, Sprague-Dawley; Up-Regulation | 2014 |
Preventive letter: doubling the return rate after gestational diabetes mellitus.
Topics: Adult; Amino Acids; C-Peptide; Chile; Chromium; Correspondence as Topic; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Health Promotion; Humans; Kaplan-Meier Estimate; Nicotinic Acids; Patient Compliance; Postnatal Care; Pregnancy; Schools, Medical | 2015 |
Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating.
Topics: Bulimia; Chromium; Depression; Diabetes Mellitus, Type 2; Dietary Supplements; Humans | 2015 |
Type 2 diabetic rats on diet supplemented with chromium malate show improved glycometabolism, glycometabolism-related enzyme levels and lipid metabolism.
Topics: Animals; Biological Transport; Blood Glucose; Body Weight; Chromium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Fasting; Gastrointestinal Microbiome; Glucose; Glycogen; Insulin; Lipid Metabolism; Liver; Malates; Male; Maze Learning; Rats | 2015 |
The Effects of Leucine, Zinc, and Chromium Supplements on Inflammatory Events of the Respiratory System in Type 2 Diabetic Rats.
Topics: Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Insulin; Leucine; Lung; Male; Oxidative Stress; Pneumonia; Rats, Wistar; Trachea; Zinc | 2015 |
Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate.
Topics: Amino Acids; Animals; Arrhythmias, Cardiac; Benzylamines; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chromium; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructose; Heart Failure; Male; Mice; Myocytes, Cardiac; Nicotinic Acids; Phosphorylation; Prediabetic State; Protein Kinase Inhibitors; Rats; Rats, Wistar; Reactive Oxygen Species; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sulfonamides | 2016 |
Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements.
Topics: Adolescent; Adult; Aged; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Nutrition Surveys; Odds Ratio; Risk Factors; United States; Young Adult | 2015 |
The adipogenic potential of Cr(III). A molecular approach exemplifying metal-induced enhancement of insulin mimesis in diabetes mellitus II.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Antigens, Differentiation; Biomimetic Materials; Cell Differentiation; Chromium; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin; Mice | 2016 |
Anti-diabetic effects of Inonotus obliquus polysaccharides-chromium (III) complex in type 2 diabetic mice and its sub-acute toxicity evaluation in normal mice.
Topics: Animals; Basidiomycota; Blood Glucose; Body Weight; Chromium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Heart; Hypoglycemic Agents; Kidney; Liver; Male; Malondialdehyde; Mice; Organ Size; Pancreas; Polysaccharides; Spleen; Thymus Gland | 2017 |
Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.
Topics: Amino Acids; Animals; Blood Glucose; Chromium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonoids; Glucagon-Like Peptide-1 Receptor; Humans; Insulin; Islets of Langerhans; Male; Mice; Mice, Knockout; Nicotinic Acids; Rats, Wistar; Rats, Zucker | 2017 |
Inverse Association of Plasma Chromium Levels with Newly Diagnosed Type 2 Diabetes: A Case-Control Study.
Topics: Adult; Asian People; Biomarkers; Blood Glucose; Body Mass Index; Case-Control Studies; China; Cholesterol, HDL; Cholesterol, LDL; Chromium; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Life Style; Limit of Detection; Male; Middle Aged; Triglycerides | 2017 |
Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
Topics: Animals; Blood Glucose; Chromium; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Evaluation, Preclinical; Glucose Tolerance Test; Inflammation Mediators; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred Strains; Milk; Muscle, Skeletal; Obesity; Signal Transduction; Tissue Distribution; Triglycerides; Weight Gain | 2009 |
Author reply: phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.
Topics: Chromium; Diabetes Mellitus, Type 2; Humans; Phenotype | 2008 |
Loss of sight and sound. Could it be the hip?
Topics: Arthroplasty, Replacement, Hip; Blindness; Chromium; Cobalt; Diabetes Mellitus, Type 2; Drug Overdose; Female; Hearing Loss; Hip Prosthesis; Humans; Hypertension; Middle Aged; Optic Nerve; Prosthesis Failure; Reoperation; Vestibulocochlear Nerve | 2009 |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats.
Topics: Adiponectin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Biomarkers; Cell Line; Chromium; Coordination Complexes; Cysteine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Dietary Supplements; Humans; Hypoglycemic Agents; Liver; Male; Monocytes; Organometallic Compounds; Oxidative Stress; Random Allocation; Rats; Rats, Zucker; Signal Transduction | 2010 |
Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats.
Topics: Amino Acids; Animals; Antioxidants; Chromium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Flavonoids; Glutathione; Glycated Hemoglobin; Hyperglycemia; Liver; Liver Glycogen; Male; Malondialdehyde; Nicotinic Acids; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2010 |
The effect of chromium on rat insulinoma cells in high glucose conditions.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Chlorides; Chromium; Chromium Compounds; Cytoprotection; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glucose; Insulin; Insulin-Secreting Cells; Rats; RNA, Messenger | 2010 |
Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
Topics: Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Humans | 2010 |
Author reply: Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
Topics: Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Humans | 2010 |
The effects of chromium complex and level on glucose metabolism and memory acquisition in rats fed high-fat diet.
Topics: Animals; Carbohydrate Metabolism; Chromium; Chromium Compounds; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Male; Memory; Rats; Rats, Wistar | 2011 |
Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelines.
Topics: Algorithms; Animals; Blotting, Western; Chromium; Comet Assay; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA Damage; Mice; Picolinic Acids; Practice Guidelines as Topic; Superoxide Dismutase; Superoxide Dismutase-1; Tumor Suppressor Protein p53 | 2011 |
Is chromium from stainless steel utensils responsible for epidemic of type 2 diabetes?
Topics: Blood Glucose; Chromium; Corticosterone; Diabetes Mellitus, Type 2; Humans; India; Insulin; Insulin Resistance; Life Style; Models, Theoretical; Prevalence; Stainless Steel | 2011 |
Characterization of the organic component of low-molecular-weight chromium-binding substance and its binding of chromium.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Cattle; Chromium; Diabetes Mellitus, Type 2; Humans; Kinetics; Molecular Weight; Oligopeptides; Peptide Fragments; Protein Binding; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry; Trace Elements | 2011 |
Impact of maternal chromium restriction on glucose tolerance, plasma insulin and oxidative stress in WNIN rat offspring.
Topics: Animals; Animals, Newborn; Antioxidants; Chromium; Diabetes Mellitus, Type 2; Enzyme Activation; Female; Gene Expression; Glucose Intolerance; Insulin; Liver; Male; Oxidative Stress; Rats | 2011 |
Favorable effects on metabolic risk factors with daily brewer's yeast in type 2 diabetic patients with hypercholesterolemia: a semi-experimental study.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromium; Diabetes Mellitus, Type 2; Female; Humans; Hypercholesterolemia; Iran; Male; Middle Aged; Risk Factors; Saccharomyces cerevisiae; Time Factors; Treatment Outcome; Triglycerides; Yeast, Dried | 2012 |
Prediction of type-2 diabetes based on several element levels in blood and chemometrics.
Topics: Adult; Chromium; Copper; Decision Trees; Diabetes Mellitus, Type 2; Discriminant Analysis; Humans; Iron; Lithium; Manganese; Middle Aged; Nickel; Predictive Value of Tests; Principal Component Analysis; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Atomic; Support Vector Machine; Trace Elements; Vanadium; Zinc | 2012 |
Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus.
Topics: Adult; Blood Glucose; Body Mass Index; Case-Control Studies; Chromium; Copper; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Iron; Spectrophotometry, Atomic; Trace Elements; Young Adult; Zinc | 2012 |
The effects of chromium picolinate and chromium histidinate administration on NF-κB and Nrf2/HO-1 pathway in the brain of diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Chelating Agents; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Heme Oxygenase (Decyclizing); Histidine; Hypoglycemic Agents; I-kappa B Proteins; Male; Nerve Tissue Proteins; Neurons; NF-E2-Related Factor 2; NF-KappaB Inhibitor alpha; Organometallic Compounds; Picolinic Acids; Rats; Rats, Wistar; Signal Transduction; Transcription Factor RelA | 2012 |
Comparative metal distribution in scalp hair of Pakistani and Irish referents and diabetes mellitus patients.
Topics: Adult; Cadmium; Chromium; Diabetes Mellitus, Type 2; Female; Hair; Humans; Ireland; Lead; Magnesium; Manganese; Middle Aged; Pakistan; Reference Standards; Scalp; Spectrophotometry, Atomic; Zinc | 2013 |
Controlling blood sugar with nutrients & botanicals.
Topics: Biotin; Blood Glucose; Chromium; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Phytotherapy; Treatment Outcome; Vanadium | 2003 |
A test for adequacy of chromium nutrition in humans--relation to type 2 diabetes mellitus.
Topics: Adult; Aged; Case-Control Studies; Chromium; Diabetes Mellitus, Type 2; Erythrocyte Membrane; Female; Humans; Male; Middle Aged; Models, Biological; Nutritional Status | 2003 |
Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus.
Topics: Case-Control Studies; Cholesterol; Chromium; Copper; Creatinine; Diabetes Mellitus, Type 2; Female; Humans; Iron; Lipid Metabolism; Lipids; Magnesium; Male; Manganese; Middle Aged; N-Acetylneuraminic Acid; Reference Values; Trace Elements; Turkey; Zinc | 2003 |
Harnessing chromium in the fight against diabetes.
Topics: Chromium; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Insulin; Micronutrients; Picolinic Acids | 2003 |
Cross talk between iron metabolism and diabetes.
Topics: Aged; Amino Acids; Arteriosclerosis; Chromium; Cytokines; Deferoxamine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose; Hemochromatosis; Humans; Insulin; Insulin Secretion; Iron; Iron Deficiencies; Nicotinic Acids; Oxidants; Receptors, Transferrin | 2004 |
Research profile. Chromium. Can it help kids with type 2? Sushil K. Jain, PhD.
Topics: Adolescent; Biomedical Research; Blood Glucose; Child; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; United States | 2004 |
Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Humans; Insulin; Lipids; Male; Middle Aged; Triglycerides | 2004 |
[Effect of food diet supplements with chromium on the clinical and metabolic parameters in type 2 diabetic patients].
Topics: Blood Pressure; Body Weight; Chromium; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Supplements; Female; Humans; Male; Middle Aged | 2004 |
Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice.
Topics: Animals; Blood Glucose; Body Weight; Carbohydrate Metabolism; Chromium; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dietary Supplements; Glucose; Glucose Tolerance Test; Insulin; Iron Chelating Agents; Kidney; Male; Mice; Mice, Inbred C57BL; Picolinic Acids; Time Factors | 2005 |
Effect of chromium on the insulin resistance in patients with type II diabetes mellitus.
Topics: Adult; Aged; Chromium; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Middle Aged; Overweight; Treatment Outcome | 2005 |
Transcriptome of the subcutaneous adipose tissue in response to oral supplementation of type 2 Leprdb obese diabetic mice with niacin-bound chromium.
Topics: Adipose Tissue; Administration, Oral; Animals; Apoptosis Regulatory Proteins; Blood Glucose; Cholesterol; Chromium; Diabetes Mellitus, Type 2; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation; Ion Channels; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Mitochondrial Proteins; Niacin; Obesity; Oligonucleotide Array Sequence Analysis; Receptors, Cell Surface; Receptors, Leptin; Transcription, Genetic; Uncoupling Protein 1; Up-Regulation | 2006 |
Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes: response to Martin et al.
Topics: Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Therapy, Combination; Humans; Insulin; Obesity; Weight Gain | 2006 |
Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Hair; Humans; Insulin; Male; Middle Aged; Spectrophotometry, Atomic; Statistics, Nonparametric | 2007 |
Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome.
Topics: Case-Control Studies; Chromium; Copper; Diabetes Mellitus, Type 2; Female; Humans; Magnesium; Male; Metabolic Syndrome; Middle Aged; Minerals; Nickel; Zinc | 2007 |
So many choices, so what's a consumer to do?: A commentary on "Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of strepto
Topics: Animals; C-Reactive Protein; Cholesterol; Chromium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Interleukin-6; Lipid Peroxidation; Nicotinic Acids; Organometallic Compounds; Picolinic Acids; Rats; Triglycerides; Tumor Necrosis Factor-alpha | 2007 |
Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats.
Topics: Animals; C-Reactive Protein; Cholesterol; Chromium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Interleukin-6; Lipid Peroxidation; Male; Nicotinic Acids; Organometallic Compounds; Oxidative Stress; Picolinic Acids; Rats; Rats, Sprague-Dawley; Triglycerides; Tumor Necrosis Factor-alpha | 2007 |
Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients.
Topics: Aged; Case-Control Studies; Chromium; Copper; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Hair; Humans; Iron; Male; Manganese; Middle Aged; Nickel; Trace Elements; Zinc | 2008 |
Chromium and polyphenols from cinnamon improve insulin sensitivity.
Topics: Blood Glucose; Chromium; Cinnamomum zeylanicum; Diabetes Mellitus, Type 2; Dietary Supplements; Flavonoids; Humans; Insulin; Insulin Resistance; Lipids; Metabolic Syndrome; Phenols; Phytotherapy; Plant Extracts; Polyphenols | 2008 |
Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
Topics: Animals; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Disease Models, Animal; eIF-2 Kinase; Endoplasmic Reticulum; Glucose Intolerance; Insulin; Insulin Resistance; Leptin; Lipids; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Protein Serine-Threonine Kinases; Thapsigargin; Trace Elements | 2008 |
Use of the artificial beta cell (ABC) in the assessment of peripheral insulin sensitivity: effect of chromium supplementation in diabetic patients.
Topics: Adult; Aged; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Fasting; Female; Humans; Insulin Infusion Systems; Insulin Resistance; Male; Middle Aged | 1984 |
Coronary risk factors in people from the Indian subcontinent.
Topics: Chromium; Coronary Disease; Diabetes Mellitus, Type 2; Diet; Humans; India; Insulin Resistance; United Kingdom | 1995 |
[Chromium in the treatment of clinical diabetes mellitus].
Topics: Blood Glucose; Chromium; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male | 1993 |
Sudden hypoglycemia in a diabetic.
Topics: Aged; Chromium; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Male | 1996 |
Blood levels of chromium in diabetic and nondiabetic hemodialysis patients.
Topics: Adult; Aged; Chromium; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Reference Values; Renal Dialysis | 1996 |
Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients--implications for the prevention of cardiovascular disease and type II diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Child; Child, Preschool; Chromium; Diabetes Mellitus, Type 2; Female; Hair; Humans; Infant; Male; Middle Aged; Sex Characteristics; Sweat | 1997 |
Chromium deficiency might contribute to insulin resistance, type 2 diabetes mellitus, dyslipidaemia, and atherosclerosis.
Topics: Arteriosclerosis; Chromium; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Insulin Resistance | 1996 |
Chromium levels in patients with internal diseases.
Topics: Adult; Aged; Blood Glucose; Blood Proteins; Cholesterol; Chromium; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Spectrophotometry, Atomic; Transferrin | 1998 |
Chromium homeostasis in patients with type II (NIDDM) diabetes.
Topics: Adult; Aged; Blood Glucose; Chromium; Diabetes Mellitus, Type 2; Fasting; Female; Homeostasis; Humans; Insulin; Male; Middle Aged | 1999 |
Chromium and diabetes.
Topics: Chromium; Diabetes Mellitus, Type 2; Humans; Randomized Controlled Trials as Topic | 1999 |
Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Cholesterol; Chromium; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glucose Tolerance Test; Humans; Insulin; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pilot Projects; Triglycerides | 2000 |
Toward a wholly nutritional therapy for type 2 diabetes.
Topics: Biotin; Chromium; Coenzymes; Diabetes Mellitus, Type 2; Dietary Supplements; Fatty Acids, Nonesterified; Humans; Linoleic Acid; Ubiquinone | 2000 |
Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus.
Topics: Adult; Aged; Chromium; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Middle Aged | 2000 |
Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls.
Topics: Aged; Chromium; Copper; Diabetes Mellitus, Type 2; Erythrocytes; Glycated Hemoglobin; Humans; Iron; Lymphocytes; Manganese; Middle Aged; Selenium; Trace Elements; Vanadium; Zinc | 2001 |
Chromium determinations in blood cells: clinical relevance demonstrated in patients with diabetes mellitus type 2.
Topics: Adult; Age Factors; Chromium; Diabetes Mellitus, Type 2; Female; Humans; Leukocytes; Male; Middle Aged; Spectrophotometry, Atomic; Trace Elements | 2002 |
Beneficial effects of hormonal replacement therapy on chromium status and glucose and lipid metabolism in postmenopausal women.
Topics: Administration, Oral; Blood Glucose; Cardiovascular Diseases; Cholesterol, LDL; Chromium; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Drug Administration Schedule; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Fructosamine; Humans; Hydrocortisone; Insulin; Leptin; Middle Aged; Postmenopause; Reference Values | 2002 |
Urinary excretion of chromium, copper, and manganese in diabetes mellitus and associated disorders.
Topics: C-Peptide; Chromium; Copper; Creatinine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Liver Diseases; Male; Manganese; Middle Aged; Reference Values; Spectrophotometry, Atomic; Trace Elements | 1991 |
[Chromium content of medicinal plants used in diabetes mellitus type II].
Topics: Chromium; Diabetes Mellitus, Type 2; Humans; Plants, Medicinal; Species Specificity | 1988 |